Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Innate Immunity is Scopus-indexed (Q1, CiteScore 9.7), WoS SCIE, DOAJ. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 1662-811XVerify ISSN ↗1662-8128Verify ISSN ↗
Publisher: S. Karger AG
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 37 / 234 | 84th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q1, CiteScore 9.7.
Journal of Innate Immunity is Q1 in Immunology and Allergy (rank 37 of 234), by CiteScore 2025.
Journal of Innate Immunity is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.7, which places it in quartile Q1 at the 84th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.408, quartile Q1, with an H-index of 91.
The publisher lists an article processing charge of about US$3,590 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Innate Immunity is published by S. Karger AG. Its print ISSN is 1662-811X and its online ISSN is 1662-8128.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Innate Immunity has an h-index of 107 and a 2-year mean of 3.66 citations per paper (OpenAlex). Its Scopus CiteScore is 9.7, quartile Q1. On 2-year citations it ranks #66 of 231 Scopus journals in Immunology and Allergy.
Journal of Innate Immunity published 37 papers in 2025; its busiest recent year was 2018 with 74. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2023–2026), authors are most often from China (28.1%), United States (17.6%) and Ireland (8.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.